Australia's most trusted
source of pharma news
Saturday, 13 December 2025
Posted 12 December 2025 PM
Ongoing global cost-cuts at Pfizer have hit Australia and news that an undisclosed number of local jobs have been lost was our top story this week.
The company has been implementing its cost realignment program since 2023 with savings getting deeper and deeper - starting at US$3.5 billion and growing to US$5.7 billion.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.